Pan, X.; Liu, C.; Stader, F.; Derbalah, A.; Jamei, M.; Gardner, I.
Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study. Pharmaceutics 2025, 17, 896.
https://doi.org/10.3390/pharmaceutics17070896
AMA Style
Pan X, Liu C, Stader F, Derbalah A, Jamei M, Gardner I.
Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study. Pharmaceutics. 2025; 17(7):896.
https://doi.org/10.3390/pharmaceutics17070896
Chicago/Turabian Style
Pan, Xian, Cong Liu, Felix Stader, Abdallah Derbalah, Masoud Jamei, and Iain Gardner.
2025. "Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study" Pharmaceutics 17, no. 7: 896.
https://doi.org/10.3390/pharmaceutics17070896
APA Style
Pan, X., Liu, C., Stader, F., Derbalah, A., Jamei, M., & Gardner, I.
(2025). Mechanistic Insights into Cytokine Antagonist-Drug Interactions: A Physiologically Based Pharmacokinetic Modelling Approach with Tocilizumab as a Case Study. Pharmaceutics, 17(7), 896.
https://doi.org/10.3390/pharmaceutics17070896
